Birgitte Volck MD, PhD

Birgitte is a seasoned biotech executive and R&D leader. She was formerly Senior Vice President and Head of R&D, Rare Disease at GSK in the UK, where she oversaw ex-vivo gene therapy programs for orphan disease indications. Prior to GSK, Birgitte was Chief Medical Officer and SVP, Head of Development at Swedish Orphan Biovitrum (SOBI), a biopharmaceutical company, leading the development of their portfolio of products and product candidates in rare diseases across hemophilia, inflammation, metabolism, neonatology, and genetics. In addition, Birgitte has held senior R&D and medical affairs positions with Genzyme, Pharmexa, and Amgen where she led early and late stage programs and worked with product commercialization from pre-approval to launch and lifecycle management. She received her M.D. and Ph.D. degrees from Copenhagen University, Denmark, where she is now an external lecturer.